Clinical Research Studies of Atimociclib in HR+/HER2- and/or HER2+ Breast Cancer supports investigators studying atimociclib combinations to generate clinical evidence for breast cancer treatment.
Bayer funds educational initiatives to enhance quality of life and patient-centered care in advanced prostate cancer, focusing on evidence-based approaches, cognitive outcomes, and survivorship.
Bayer funds educational programs advancing knowledge of new therapies, treatment strategies, and quality of life in advanced prostate cancer.
Bayer funds educational projects to advance treatment strategies and clinical trial innovations in metastatic hormone-sensitive prostate cancer (mHSPC).
Scientific Research Grants support researchers pursuing innovative breast cancer pilot studies to transform detection and treatment, reduce mortality, and prevent metastasis or relapse.